MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+47.8%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$355M
AUM Growth
+$355M
(+57%)
Cap. Flow
+$71.4M
Cap. Flow
% of AUM
20.13%
Top 10 Holdings %
Top 10 Hldgs %
99.41%
Holding
11
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$68.1M |
| 2 |
HSTO
Histogen Inc. Common Stock
HSTO
|
$12M |
Top Sells
| 1 |
Verastem
VSTM
|
$8.75M |
Sector Composition
| 1 | Healthcare | 56.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $115M | 32.49% | 2,880,485 | – | – |
|
|
PETX
2
DELISTED
Aratana Therapeutics, Inc.
PETX
| $71.1M | 20.05% | 4,351,048 +4,170,543 | +2,310% | +$68.1M |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $65.3M | 18.41% | 2,441,344 | – | – |
|
4
Pacira BioSciences
PCRX
$1.2B
| $39.6M | 11.17% | 824,255 | – | – |
|
5
Altimmune
ALT
$338M
| $13.3M | 3.76% | 6,347,614 | – | – |
|
|
6
Verastem
VSTM
$569M
| $12.9M | 3.63% | 1,033,324 -702,847 | -40% | -$8.75M |
|
|
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
| $12M | 3.38% | +1,192,080 | New | +$12M |
|
|
KBIO
8
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $11.9M | 3.36% | 2,632,928 | – | – |
|
|
ZLCS
9
DELISTED
ZALICUS INC COM NEW
ZLCS
| $6.68M | 1.88% | 5,566,980 | – | – |
|
|
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.55M | 1.28% | 2,208,961 | – | – |
|
|
ETRM
11
DELISTED
EnteroMedics Inc.
ETRM
| $2.09M | 0.59% | 1,669,753 | – | – |
|